Detailed Information on Publication Record
2009
Modulation of cell proliferation and differentiation of human lung carcinoma cells by the interferon-alpha
KREJČOVÁ, Daniela, Jiřina PROCHÁZKOVÁ, Jiří PACHERNÍK and Lukáš KUBALABasic information
Original name
Modulation of cell proliferation and differentiation of human lung carcinoma cells by the interferon-alpha
Authors
KREJČOVÁ, Daniela (203 Czech Republic), Jiřina PROCHÁZKOVÁ (203 Czech Republic), Jiří PACHERNÍK (203 Czech Republic) and Lukáš KUBALA (203 Czech Republic, guarantor)
Edition
GENERAL PHYSIOLOGY AND BIOPHYSICS, 2009, 0231-5882
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
Genetics and molecular biology
Country of publisher
Slovakia
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 0.741
RIV identification code
RIV/00216224:14110/09:00028863
Organization unit
Faculty of Medicine
UT WoS
000272335700010
Keywords in English
Non-small cell lung cancer; ABC transporter proteins; Cell cycle; Interferons
Tags
International impact, Reviewed
Změněno: 1/7/2010 10:10, Mgr. Jiřina Medalová, Ph.D.
Abstract
V originále
Interferon alpha (IFN-alpha), an important physiological immunomodulator, possesses direct cytotoxic and cytostatic effects on tumour cells, antiangiogenic effects, and activates anti-tumour immunity. Herein the human lung carcinoma cell line A549, a model of NSCLC in vitro, was used to pursue the effect of IFN-alpha on A549 cell proliferation and differentiation together with the effect on protein expression and activity of three ATP-transporters mediating multi-drug resistance (MDR). IFN-alpha significantly inhibited the proliferation of A549 cells which was not connected with arrest in a particular cell cycle phase. IFN-alpha-mediated differentiation of A549 was observed based on an increase in alkaline phosphatase activity. Simultaneously, IFN-alpha increased the expression and activity of ATP-transporters mediating MDR. The IFN-alpha down-regulation of NSCLC cell proliferation was accompanied by a potential of cells to exclude potential therapeutic substances such as chemotherapeutic agents.